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Introduction
Advertising nutritional supplements with health claims is becoming 
increasingly common in South Africa. References to research that 
is included in these advertisements may lend credibility to certain 
claims and promote the marketing of these products. Yet cited 
research that is contained in advertisements may not always be 
appropriate, sufficient or valid for the products being advertised.1-3 
A study that was carried out among Stellenbosch University students 
in 2003 showed that 42% of the 400 sampled students regularly 
consumed supplements, while 19.5% sporadically took supplements 
when stressed, tired or ill.4 Steele and Senekal found that the 
reasons that were provided by regular supplement users for taking 
supplements reflected the advertising strategies of supplement 
manufacturers. Furthermore, participants indicated that the main 
source of information about supplements were family and friends, 
followed by doctors and advertisements.4 Therefore, advertisements 
may play a considerable role in informing potential consumers. It is 
crucial that the information about supplements in advertisements is 
accurate.
Nutritional supplements are inadequately regulated in South Africa. 
Their regulation is meant to be provided for either by the Medicines 
and Related Substances Act (Act 101 of 1965),5 or the Foodstuffs, 
Cosmetics and Disinfectants Act (Act 54 of 1972).6 However, there 
is ongoing debate about which Act is applicable and a final decision 
about this is still pending. The Advertising Standards Authority, an 
industry body, can in some cases intervene in the case of misleading 
claims to prevent further advertising of an ambiguous product in the 
media, e.g. regarding supplements that include weight-loss claims, 
over-the-counter medicines and protein claims relating to food and 
smoking deterrent products. However, they cannot prevent the sale of 
these products or stop misleading advertising in areas in which they 
have no jurisdiction, e.g. nutritional supplements that include claims 
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about cardiovascular health, cancer protection, detoxing and acne. 
The Medicines Control Council recently published draft regulations 
for the management of complementary and alternative medicines,7 
but they do not contain any criteria to determine the efficacy and 
safety of nutritional supplements. Promulgation of the new food 
labelling and advertising legislation in March 2010 in South Africa 
was a welcome development, but currently, this legislation only 
covers health claims on food packaging and not those that relate to 
nutritional supplements. The Foodstuffs, Cosmetics and Disinfectants 
Act defines a food claim as “any written, pictorial, visual, descriptive 
or verbal statement, communication, representation or reference 
brought to the attention of the public in any manner, including a 
trade name or brand name, and referring to the characteristics of 
a product, in particular to its nature, identity, nutritional properties, 
composition, quality, durability, origin or method of manufacture or 
production”.6 However, this definition does not explicitly refer to 
health effects.
In contrast, the regulation of nutrition and health claims for both food 
and nutritional supplements, and the advertising thereof, has been 
in place in the EU since 2007.8 In the EU, a health claim is defined 
as “any claim that states, suggests or implies that a relationship 
exists between a food category, a food or one of its constituents 
and health”. More specifically EU regulations refer to a “reduction 
of disease risk claim” as “any health claim that states, suggests or 
implies that the consumption of a food category, a food or one of its 
constituents significantly reduces a risk factor in the development of 
a human disease”. Furthermore, the European Food Safety Authority 
has specified wording for claims that are allowed on the packaging of 
relevant food and nutritional supplements.8 In the USA, the Nutrition 
Labeling and Education Act of 1990 requires that health claims on 
food and nutritional supplements are made with the approval of the 
US Food and Drug Administration (FDA).9
This study sought to provide information on health claims that were 
made in nutritional supplement advertisements in South Africa. South 
African women’s magazines were sampled over a one-year period 
to determine the number of nutritional supplements covered, what 
percentage of these advertisements contained health claims, and of 
these, what percentage cited research. The evidence level and study 
characteristics were then assessed to determine the appropriateness 
of the cited research for the health claims that were made.
Method
Selection of study sample 
The Audit Bureau of Circulations (ABC) of South Africa was contacted 
in July 2010 to identify the five registered women’s magazines with 
the highest circulation figures. These magazines, in alphabetical 
order, are Cosmopolitan, Finesse, Move!, Rooi Rose and Sarie. Move! 
is published weekly, and the others, monthly. Cosmopolitan and 
Move! are published in English, while Finesse, Rooi Rose and Sarie 
are published in Afrikaans. The number of South Africans who read 
these five women’s magazines, as well as demographic information 
estimated for 2011 by the South African Advertising Research 
Foundation (SAARF), is displayed in Table I.10
For the period September 2010 to August 2011, all issues of the 
monthly magazines and the first issue in each month of the weekly 
magazine (60 issues in total) were purchased. Each magazine issue 
was screened at least twice by the first author to identify potentially 
eligible advertisements. Then the first and second authors used the 
following pre-specified eligibility criteria to finalise the sample: an 
advertisement that specified or named at least one supplement 
intended for oral consumption by people; the supplement could be 
in any form, e.g. a tablet, capsule, gel, powder or liquid, as long as 
it contained at least a vitamin, mineral, herb (or other botanical), 
amino acid, carbohydrate or fatty acid; and it was not allowed to be 
a functional food.
Data extraction
A 22-question data extraction form was designed and piloted to 
guide data collection. This form included closed- and open-ended 
questions and consisted of different sections, namely general 
(product and manufacturer’s name, contact details, months and 
magazines in which the advertisements were published), and 
quotes (health claims, referrals to research or statistics, persuasive 
remarks, and anecdotes or recommendations). The Levels of 
Evidence tool, developed by Oxford University’s Centre for Evidence-
based Medicine, was used to determine the level of evidence that 
was cited in the advertisements.11  Finally, after reading the full 
text of the cited articles, the appropriateness or directness of the 
research was assessed by taking the study design, types of study 
participants, interventions, controls and outcome measures (primary 
outcomes) into account.














B C I W Afr Eng Xho Zul Oth 1-24 25-34 35-49 ≥ 50 LSM 1-4 LSM 5-8 LSM 9-10
Cosmopolitan 833 000 2.4 (2.21-2.29) 54.4 9.8 7.6 28.1 15.2 32.9 12.2 17.0 22.7 28.1 29.4 28.6 13.9 1.6 54.0 44.4
Finesse 245 000 0.7 (0.6-0.8) 5.3 29.8 0.4 64.9 83.3 11.4 3.7 0 1.6 14.6 15.8 26.0 43.6 1.1 42.7 56.2
Move! 2475 000 7.1 (6.78-7.42) 96.4 2.7 0.3 0.6 3.1 3.4 14.3 20.6 58.6 41.2 29.7 21.5 7.6 13.2 74.2 12.6
Rooi Rose 909 000 2.6 (2.4-2.8) 23.3 32.0 0.5 44.2 67.2 10.6 2.4 1.6 18.2 19.3 18.5 30.8 31.4 10.4 56.4 33.2
Sarie 868 000 2.5 (2.31-2.59) 20.6 30.0 0.6 48.8 70.5 10.0 2.6 2.0 14.9 16.8 17.3 31.4 34.3 8.6 54.8 36.6
* Readership between January and December 2011 was estimated by the South African Advertising Research Foundation (SAARF) by asking the surveyed respondents whether or not they had read a copy of a 
specific magazine within a certain period prior to the survey. The period was no longer than the issue period of that magazine, i.e. within seven days for a weekly magazine.10
** Denominator is South Africa, with an estimated 34 million people aged ≥ 15 years in 2011.10
*** Living standards measure (LSM), which is a wealth measure based on standard of living, rather than income. The higher the living standards measure group, the wealthier the household, e.g. has hot running 
water, a refrigerator and freezer, an electric stove and a home security service.10
Afr: Afrikaans, B: black, C: coloured, CI: confidence interval, Eng: English, ER: estimated readership, I: Indian, Oth: other, W: white, Xho: Xhosa, Zul: Zulu
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The criteria that were used to assess the level and appropriateness 
of cited research are provided in Table II. One data extraction form 
per nutritional supplement was completed, using information from 
all relevant advertisements for a specific product during the course 
of the year. 
Analysing data
Data were summarised in a diagram, bar chart and table. The health 
claims of the nutritional supplements were grouped into various 
categories, e.g. weight loss and toning, immune system and energy, 
cardiovascular health, and joint and cartilage, according to the 
broader health area to which the main or first health claim applied. 
Ethics
As the data source of this project was advertisements that were in the 
public domain, the Health Research Ethics Committee of Stellenbosch 
University provided ethics review exemption (N11/10/306).
Results
In total, 486 eligible advertisements referring to 158 different 
nutritional supplements were identified. Figure 1 displays the 
number of nutritional supplement advertisements according to 
month and magazine. There were no eligible advertisements in 
Move! Almost all of the advertisements (96.7%) were sourced from 
Table II: Levels of evidence for health claims and criteria for appropriateness11
Level Study design
1 Systematic review of RCTs: First-prize evidence of health claims’ effectiveness
2 Individual RCT (with narrow confidence interval): Gold standard for primary research on effectiveness
3 Systematic review of cohort studies
4 Individual cohort study (and low-quality RCT, e.g. < 80% follow-up)
5 “Outcomes” research and ecological studies
6 Systematic review of case control or cross-sectional studies
7 Individual case control or cross-sectional study
8 Case series (and poor quality cohort and case control studies, and uncontrolled studies)
9 Expert opinion, animal research and laboratory studies








Appropriate study design: Ideally systematic reviews of RCTs, otherwise individual RCTs.
Appropriate participants: Humans diagnosed with the specific outcome of interest where eligibility criteria were reasonable and 
reported baseline characteristics per group were similar to the product’s target market.
Appropriate intervention: The product being advertised (preferably as a whole, otherwise evidence is needed for all ingredients) where 
the dose and frequency of use are similar to the product instructions. There may have been a co-intervention, provided it was also 
given to the control group.
Appropriate control: Standard treatment or placebo.
Appropriate primary outcomes: Patient-important clinical outcomes.
RCT: randomised controlled trial
Cosmopolitan
n = 16 (3.3%)
Summer (22.2%)
December, n = 37
January, n = 30
February, n = 41
Finesse
n = 137 (28.2%)
Autumn (28.6%)
March, n = 28
April, n = 21
May, n = 90
Move!
n = 0 (0%)
486 advertisements referred to 
158 nutritional supplements
Winter (22.0%)
June, n = 46
July, n = 30
August, n = 31
Rooi Rose
n = 202 (41.5%)
Sarie
n = 131 (27%)
Spring (27.2%)
September, n = 33
October, n = 50
November, n = 49
Figure 1: Number of nutritional supplement advertisements (n = 486) according to month and magazine for the period September 2010 to August 2011
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the three Afrikaans language magazines. 
The proportions of eligible advertisements 
across the four seasons of the year were 
similar, ranging from 22% in winter to 
28.6% in autumn.  
Health claims were made for 137 
(86.7%) of the 158 identified nutritional 
supplements which covered a wide 
range of conditions (see Figure 2). The 
most common claims related to weight 
loss and body toning (22.6%), and the 
immune system and energy boosting 
(13.9%) category. The category “Other” 
represented seven nutritional supplements 
in instances when the main health claim 
did not fall into any other category. These 
seven products contained health claims 
relating to diarrhoea, prostate health, 
menopausal symptoms, enhancing a tan, 
cold sores, school performance, as well as 
hair, skin and nail health. 
In Table III, illustrative quotes are presented from the three categories 
with the highest number of health claims, as well as from the 
categories’ “multiple conditions” and “acne”.
Only nine (6.6%) of the 137 nutritional supplement advertisements 
with health claims cited research. Table IV shows the nature of 
the cited research, including the level of evidence and study 
characteristics. Seven of 15 (46.7%) citations were judged to be 
inappropriate in terms of study design because they were laboratory 
studies, expert opinion (websites and a product monograph that 
referred to a textbook), a package insert and an uncontrolled trial. 
No systematic reviews were cited. Most of the cited randomised 
controlled trials (RCTs) had small sample sizes and a long list of 
exclusion criteria. These factors would limit the applicability of 
study findings to a broader group of patients suffering from various 
conditions. Antistax® is the only product whose direct efficacy was 
tested in a RCT. The other cited studies only investigated the efficacy 
of specific ingredients or their association with certain outcomes, 
while the product as an entity was not studied. The longest 
intervention period was 12 weeks which is insufficient to draw 
conclusions about the long-term benefits or safety of the product. All 
controlled trials cited were placebo-controlled. 
Finally, it is worth noting that several advertisements used 
arguments other than research evidence to persuade consumers. 
Examples include citing Bible verses “… and also that every man 
should eat and drink and enjoy the good of all his labour; it is the 
gift of God” (translated from Afrikaans, New King James Version, 
Ecclesiastes 3:13; Cosmo Slimming Solutions); thanking God for the 
product “our deepest thanks to the Creator who lets these herbs 
grow that we may use them” (translated from Afrikaans, Essies 
Tea); reassuring potential consumers of the product’s efficacy and 
safety by mentioning that doctors and pharmacists endorse the 
product “prescribed by doctors, recommended by pharmacists” 
(Solal Technologies); and implying that the product is a necessity 
“you will have to eat enormous portions of calcium-rich foods 




































































































































































Figure 2: Range of health claims (n = 137) that appeared in the included advertisements
Table III: Selected health claim quotes for the specified categories
Weight loss and toning
•	 Slender Max Glucoslim®: “Slim down and feel immediately satisfied by 
this stimulant-free solution that is clinically proven to work”.*
•	 Ultima 1® and Ultima Burnxpress®: “With Ultima1® and Burnxpress® 
you have the perfect weight loss combination to not only lose weight 
fast, but keep it off forever”.
•	 Organo-Slim®: “Organo-Slim works by normalising your blood sugar 
levels so that you have a reduced craving for sweets. This makes it 
much easier to eat healthily because you lose your appetite for junk 
food. It also reduces the absorption of calories and helps your tummy 
to work regularly”.*
Immune system and energy
•	 Vita-thion®: “vita-thion® is the only registered supplement in South 
Africa that gives you sustainable energy because it contains ATP”.*
•	 Solal All You Need Teens™: “Contains high dosages of vitamins, 
minerals and herb extracts that decrease stress and enhance brain 
function. It also contains probiotics and antioxidants for a stronger 
immune system and spirulina for detox”.*
Mental health
•	 Vital® Ginkgo Biloba: “Survive exams and think on your feet with this 
wonder herb. Ginkgo biloba is widely used in Western medicine as an 
aid for poor memory and concentration”.
•	 Solal Theanine®: “Helps the brain to relax and enhances brainwave 
function which enhances sleep”.*
Multiple conditions
•	 Essies® tea: “Prevents the build-up of excess fat in the veins, heart, 
kidneys and liver; regulates cholesterol by converting sugar and fat 
into energy; neutralises acids, absorbs toxins in the intestines and 
eliminates both; prevents and slow down the formation of tumours; 
and removes heavy metals around joints to reduce inflammation and 
stiffness”.*
Acne
•	 Clear Skin B5®: “It shrinks the pores, reduces the functioning of 
oil glands and heals the colour and texture of your skin. It provides 
sufficient coenzyme A, which regulates hormones and breaks down 
oil on the skin. Clinical research shows that it is just as effective as 
accutane or roaccutane, but without the side-effects. As a 100% 
natural product, it is safe and much more effective than any other 
antibiotic for acne on the market today”.*
*These quotes were translated from Afrikaans to English by one of the authors.
ATP: adenosine triphosphate
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Table IV: Nature of evidence cited in sampled advertisements
Nutritional supplement Health claim category Level of evidence Sample size Study characteristics
Antistax®
Ingredients: One tablet contains 
360 mg Antistax®.
Instructions: One tablet daily 
before breakfast, which may be 
increased to 2 tablets daily.
Chronic venous 
insufficiency 
RCT 260 Participants: Men and women (25-75 years) with stage 
1-2 CVI in Germany. There was a long list of exclusion 
criteria, such as insulin-dependent diabetics, those with 
renal failure, liver disease, peripheral arterial disease, 
malignancies, neuropathies, hyper- or hypocalcaemia, 
decompensated heart pump failure, oedema that did not 
relate to CVI, drug or alcohol abuse, and patients who 
required acute specific treatment for venous disorders. 
Baseline characteristics per group were reported for age, 
gender, weight, height and BMI.
Intervention 1: Antistax® 360 mg daily for 12 weeks.
Intervention 2: Antistax® 720 mg daily for 12 weeks.
Control: Placebo.
Outcome: Change in lower leg volume.
Ensure®
Description: Meal replacement 
containing numerous vitamins, 
minerals and FOSs. 
100 ml provides 420 kilojoules, 
3.72 g protein, 3.27 g fat, 13.42 g 
carbohydrates and 1.01 g FOSs.
Immune system and 
energy
Expert opinion - -
eye q™
Ingredients: Two capsules contain 
800 mg fish oil omega-3 (which 
gives 186 mg EPA and 58 mg 
DHA), 200 mg evening primrose oil 
omega-6 (which gives 20 mg GLA), 
and 3.6 mg natural vitamin E).
Instructions: Six capsules daily 
with food for the first 12 weeks, 
and 2 capsules daily thereafter.
School performance 
(part of category called 
“Other”)
RCT 117 Participants: Mainstream school children (5-12 years) 
with developmental coordination disorder in the UK. 
Eligibility criteria excluded children with epilepsy, 
diabetes, depression and chronic fatigue syndrome. 
Baseline characteristics per group were not reported.
Intervention: Supplement containing 732 mg omega-3, 
60 mg omega-6 and 9.6 mg vitamin E for 3 months.
Control: Placebo.
Outcomes: Change in motor function, reading and 
spelling, and teacher-rated attention-deficit hyperactivity 
disorder-related symptoms.
HeartChoice™ Optimal with 
CoQ10
Ingredients: One capsule contains 
150 mg coenzyme Q10, 15 mg 
resveratrol and 15 mg magnesium.
Instructions: One capsule daily.









Participants: Hispanic and African-American women of 
whom 50 were premenopausal and 48 postmenopausal 
(15 on HRT). Baseline characteristics per group were 
provided for age, weight, LDL and HDL cholesterol, total 
cholesterol and triglyceride levels.
Exposure: Natural menopause and HRT.
Outcome: Serum levels of coenzyme Q10.
Nativa Hormonal Complex®
Ingredients: 160 mg piceae pollen/
pollen-pistil extract and 7.85 mg 
vitamin E.
Instructions: Two tablets daily for 3 
months. Thereafter, the dosage can 
be adjusted to individual needs.
Menopausal symptoms 
(part of category called 
“Other”)
Uncontrolled trial 417 Participants: Menopausal women in France with 
menopausal symptoms and those not on medication. 
Eligibility criteria excluded people with hot flushes and/
or night sweats not associated with the menopause. 
Baseline characteristics were reported for age, weight, 
height and BMI.
Intervention: Sérélys® to provide daily 10 mg vitamin E, 
80 mg pollen extract (GC FEM), and 240 mg cytoplasmic 
pollen and pistil extracts (PI 82) for 84 days.
Outcome: Descriptively assessed hot flush occurrence, 
irritability, fatigue and quality of life.
Procydin®
Ingredients: 70 mg 
proanthocyanidin (from grape seed 
extract), 30 mg calcium ascorbate, 
30 mg bioflavonoids and 15 mg 
vitamin E.
Instructions: Adults weighing  
< 70 kg should take 3 capsules 
simultaneously in the morning 
for 3 days, then 2 capsules daily 
for 5 days, thereafter 1 capsule 
daily; whereas adults weighing 
≥ 70 kg should take 3 capsules 
simultaneously in the morning 
for 5 days, and 2 capsules daily 
thereafter.
Multiple disorders RCT 27 Participants: Men and women (25-80 years) in the USA 
with metabolic syndrome. Eligibility criteria excluded 
smokers and those with clinical evidence of coronary 
heart artery, pulmonary, gastrointestinal or renal disease. 
Baseline characteristics were reported per group for age, 
gender, waist circumference, BMI, glucose and insulin 
levels, as well as LDL cholesterol levels.
Intervention 1: Grape seed extract 300 mg/day for  
4 weeks.
Intervention 2: Grape seed extract 150 mg/day for  
4 weeks.
Control: Placebo.
Outcome: Mean daytime systolic and diastolic blood 
pressure.
17
Original Research: The advertising of nutritional supplements in South African women’s magazines: a descriptive survey
2013;26(2)S Afr J Clin Nutr
calcium requirements if Caltrate® Plus is not part of your daily diet” 
(translated from Afrikaans, Caltrate® Plus).  
Discussion
This study found that most nutritional supplement advertisements 
in five popular South African women’s magazines contained health 
claims that related to the prevention or treatment of a variety of 
conditions. Research to support these claims was cited in only a 
few advertisements, and this research was judged to be largely 
inappropriate because of the study design (risk of bias) or lack 
of applicability of the evidence, or both. Furthermore, several 
advertisements contained nonscientific arguments aimed at 
convincing consumers of the value of a particular supplement, e.g. 
the use of Biblical text or endorsement by healthcare professionals. 
This situation is unacceptable as it increases the likelihood of 
consumers being misled by unscrupulous marketing. Disingenuous 
advertising is forbidden by the Medicines and Related Substances 
Act5 which states that “no person shall in any advertisement make 
any claim to the effect that the therapeutic efficacy and effect of 
any medicine is other than that stated by the (Medicines Control) 
Council”. However, it is not clear from the Act what research criteria 
need to be met in order for a legitimate health claim to be made. 
Advertising of healthcare products has been studied elsewhere. 
Othman et al conducted a systematic review of the quality of 
pharmaceutical advertisements that related to prescription products 
in medical and pharmaceutical journals.12 Twenty-four studies, 
conducted in 26 countries, were included in the review. The 
authors found that fewer than 67% of the claims were supported 
by a systematic review, meta-analysis or RCT, and that most of 
the advertisements with quantitative information presented effects 
with relative rather than absolute measures of risk. Dumville et al 
investigated advertisements relating to wound care products and 
identified 217 unique advertisements from 40 wound journal issues 
and 154 from 24 British Medical Journal (BMJ) issues.13 Eighty-nine 
per cent of advertisements in the wound care journals and 84% in 
BMJ contained at least one product claim. In 35% of advertisements, 
the claims that were made cited at least one study, of which 33% 
were RCTs, compared to 63% of advertisements in the BMJ, of 
which 75% were RCTs. 
In the field of nutrition, Lobb recently investigated the health claims 
of a mangosteen supplement in a case study, and found that claims 
“overstate the significance of findings, and fail to disclose severe 
methodological weaknesses of the research they cite”.14 The author 
recommended that manufacturers of health products should include 
full disclosure of the size of the research, the duration, funding 
source and quality of research that is pertinent to product claims. 
Findings are in agreement with those of the current study, which 
showed that health claims in advertisements aimed at healthcare 
professionals were as common as those in advertisements which 
Promato®
Ingredients: 10 mg lycopene and 
150 mg ellagic acid.
Instructions: One capsule daily 
after meals.
Breast protection (but a 
second health claim in 










Participants: Histologically proven benign prostate 
hyperplasia in men in Germany who were free of prostate 
cancer and had serum PSA levels > 4 μg/l. Eligibility 
criteria excluded people with liver and kidney diseases, 
inflammatory diseases of the urogenital tract, chronic 
inflammatory bowel disease, prostate malignancies, 
those having testosterone treatment and fat 
malabsorption or maldigestion. Baseline characteristics 
per group were reported for age, height, weight, BMI, 
energy intake, dietary lycopene intake, glucose levels, 
total cholesterol and LDL cholesterol levels, and for total 
testosterone and free testosterone levels.
Intervention: Lycopene 15 mg/day for 6 months.
Control: Placebo.
Outcome: Serum PSA levels.
Participants: Men with professional jobs in America  
(40-75 years) without any cancer at baseline.
Exposure: Total lycopene intake, where high levels of 
intake were compared to the lowest level of intake.
Outcome: Incidence of prostate cancer after being 
followed-up for 12 years.
Prozen®
Ingredients: 100 mg L-theanine as 
Suntheanine®.
Instructions: One to two tablets 
daily after a meal as needed to 
a maximum of 6 daily in divided 
dosages.
Stress and anxiety Cross-over trial 
(unclear whether 
randomised or not. 
The information was 
only available in the 
form of a congress 
abstract).
22 Participants: Men in Japan (average age 27); 12 of the 
22 were daytime workers.
Intervention: Suntheanine® (pure L-theanine) 200 mg  
for 6 days, one hour before bedtime.
Control: Placebo.
Outcome: Sleep performance measured by interviews 
upon awakening.
Solal Irvingia Plus™ Fat Burner
Ingredients: 150 mg Irvingia 
gabonesis extract, 150 mg bile 
acids, 8 mg zinc and 200 μg 
chromium polynicotinate.
Instructions: One to two capsules, 
twice a day, on an empty stomach.






Participants: Overweight men and women in Cameroon 
with BMI 26-40 kg/m2.
Intervention: 150 mg Irvingia gabonesis extract 
(IGOB131) 30-60 minutes before lunch and dinner for  
10 weeks.
Control: Placebo.
Outcome: Body weight (kg).
BMI: body mass index, CVI: chronic venous insufficiency, DHA: docosahexaenoic acid, EPA: eicosapentaenoic acid, FOS: fructo-oligosaccharide, GLA: gamma-linolenic acid, HDL: high-density lipoprotein, HRT: 
hormone replacement therapy, LDL: low-density lipoprotein, PSA: prostate-specific antigen, RCT: randomised controlled trial
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targeted the general public, and that high-level evidence from 
systematic reviews and RCTs is infrequently cited.  
Advertisements for nutritional supplements appear to be an 
important source of revenue for South African women’s magazines. 
Therefore they will continue to be attractive to publishers. However, 
stricter control over the nature of advertisements, especially those 
with health claims, is needed. The findings of this study strengthen 
the case for regulation of the nutritional supplement industry. South 
Africa can learn from the experience in other countries where 
models of regulation have been adopted. Establishing criteria for 
permissible health claims requires support from good research 
evidence, and in the case of interventions, this means systematic 
reviews of RCTs. In the EU, for example, the main scientific criterion 
for scientific substantiation of health claims is “generally accepted 
scientific evidence (achieved) by taking into account the totality 
of the available scientific data, and by weighing the evidence”.15 
This relates to specific study characteristics, which are similar to 
the criteria that were used to judge the appropriateness of cited 
research in this study. 
Recently, van Loveren et al reflected on EU health claim assessments 
of prebiotic and probiotic supplements and pointed out that 
challenges include claims targeting healthy populations while most 
experimental studies have been conducted among patients.16  In the 
USA, the FDA uses an evidence-based review system for the scientific 
evaluation of health claims”.17 However, following a number of legal 
challenges by manufacturers of dietary supplements, the FDA has 
been directed to allow dietary supplement claims that do not meet 
rigorous scientific criteria through a disclaimer that aims to reduce 
the claim’s potential to mislead.  
Study limitations
The findings of this study were based on one sample of 
advertisements from women’s magazines with the highest circulation 
figures (as in July 2010) and cannot necessarily be extrapolated 
to all advertisements of nutritional supplements in South Africa. 
Other popular magazines, such as Huisgenoot and You could also 
have been sampled. However, the authors of this study wanted 
to focus on a specific type of magazine and decided on women’s 
magazines. They could just as easily have focused on health and 
fitness magazines or family magazines. The South African ABC has 
a list of registered women’s magazines in South Africa. Therefore, 
the authors asked them to indicate the most popular five. In this 
way, the sample for this study was obtained from an independent 
body. The ABC regulates circulation figures, which differ from the 
SAARF’s readership figures. A “reader” is defined as someone who 
reads or pages through all or parts of a magazine issue, irrespective 
of whether or not it is the person’s copy or someone else’s, or the 
latest issue or an old issue.18 On the other hand, the circulation figure 
is the number of each issue (per month or averaged per year) that 
gets distributed to magazine subscribers and retailers.
Data extraction was performed by one person while a second person 
quality checked 25% of the data. Although no major discrepancies 
were found regarding health claims, quotes and the level and 
appropriateness of evidence, it would have been ideal to utilise data 
extraction that had been performed independently and in duplicate.
Conclusion
Advertisements of nutritional supplements in five South African 
women’s magazines are widespread and often contain health 
claims. The South African consumer should be protected against 
misleading advertisements. Therefore, urgent measures are needed 
in South Africa to improve the regulation of advertising and the sale 
of nutritional supplements. Basic knowledge of the principles of 
evidence-based health care and nutrition should also be promoted 
in South Africa to help consumers make informed decisions about 
disease prevention and self-medication.  
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